Association of viral load with serum biomakers among COVID-19 cases
Fengjuan Shi(Jiangsu Provincial Center for Disease Control and Prevention), Bin Wu(Union Hospital), Tao Wu(Southern Medical University Shenzhen Hospital), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Baoli Zhu(Nanjing Medical University), Xiaojuan Zhu(Liaoning Normal University), Xuefei Du(Nanjing Municipal Center for Disease Control And Prevention), Ying Chi(China Three Gorges University), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Xiaoyan Zeng(Jiangsu Provincial Center for Disease Control and Prevention), Liguo Zhu(Jiangsu Provincial Center for Disease Control and Prevention)
Cited by 94
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268